BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 472724)

  • 1. 3-Methoxy-4-hydroxyphenethyleneglycol production by human brain in vivo.
    Maas JW; Hattox SE; Greene NM; Landis DH
    Science; 1979 Sep; 205(4410):1025-7. PubMed ID: 472724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A direct method for studying 3-methoxy-4-hydroxyphenethyleneglycol (MHPG) production by brain in awake animals.
    Maas JW; Hattox SE; Landis DH; Roth RH
    Eur J Pharmacol; 1977 Dec; 46(3):221-8. PubMed ID: 412681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The determination of a brain arteriovenous difference for 3-methoxy-4-hydroxyphenethyleneglycol (MHPG).
    Maas JW; Hattox SE; Landis DH; Roth RH
    Brain Res; 1976 Dec; 118(1):167-73. PubMed ID: 825199
    [No Abstract]   [Full Text] [Related]  

  • 4. Variance in the production of homovanillic acid and 3-methoxy-4-hydroxyphenethyleneglycol by the awake primate brain.
    Maas JW; Hattox SE; Landis DH
    Life Sci; 1980 Mar; 26(12):929-34. PubMed ID: 6771478
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma 3-methoxy-4-hydroxyphenethyleneglycol in pheochromocytoma.
    Lehnert H; Walger P
    Cardiology; 1985; 72 Suppl 1():160-2. PubMed ID: 4053125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covariance of plasma free 3-methoxy-4-hydroxyphenethyleneglycol and diastolic blood pressure.
    Leckman JF; Maas JW; Heninger GR
    Eur J Pharmacol; 1981 Mar; 70(2):111-20. PubMed ID: 7262184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension.
    Ferrier C; Jennings GL; Eisenhofer G; Lambert G; Cox HS; Kalff V; Kelly M; Esler MD
    J Hypertens; 1993 Nov; 11(11):1217-27. PubMed ID: 8301103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physiological role and clinical significance of 3-methoxy-4-hydroxyethyleneglycol, a noradrenaline metabolite (review of the literature)].
    Bol'shakova TD; Shenderovich MIa
    Vopr Med Khim; 1987; 33(6):3-11. PubMed ID: 3328414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the isolated perfused mouse brain as a system for neurochemical studies.
    Towell JF; Erwin VG
    Brain Res; 1981 Mar; 209(2):476-81. PubMed ID: 6112042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the origin of vanillylmandelic acid and 3-methoxy-4-hydroxy-phenylglycol in the rat brain.
    Adèr JP; Muskiet FA; Jeuring HJ; Korf J
    J Neurochem; 1978 Jun; 30(6):1213-6. PubMed ID: 670965
    [No Abstract]   [Full Text] [Related]  

  • 11. Disposition and metabolism of MHPG-CD3 in humans: plasma MHPG as the principal pathway of norepinephrine metabolism and as an important determinant of CSF levels of MHPG.
    Kopin IJ; Blombery P; Ebert MH; Gordon EK; Jimerson DC; Markey SP; Polinsky RJ
    Adv Biochem Psychopharmacol; 1984; 39():57-68. PubMed ID: 6464833
    [No Abstract]   [Full Text] [Related]  

  • 12. A method for the preparation and separation of 3-methoxy-4-hydroxyphenethyleneglycol conjugates.
    Yeh EL; Landis DH; Maas JW
    Biochem Med; 1975 Dec; 14(4):411-6. PubMed ID: 819012
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of acute and chronic morphine administration on the levels of 3-methoxy-4-hydroxphenylglycol sulfate in rat brain.
    Roffman M; Reigle T; Orsulak P; Schildkraut JJ
    Res Commun Chem Pathol Pharmacol; 1975 Mar; 10(3):403-17. PubMed ID: 1135507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-hydroxy-3-methoxyphenylglycol as an index of brain noradrenaline turnover in endogenous depression.
    Riederer P; Birkmayer W; Seemann D; Wuketich S
    Acta Psychiatr Scand Suppl; 1980; 280():251-7. PubMed ID: 6996431
    [No Abstract]   [Full Text] [Related]  

  • 15. Norepinephrine metabolism in humans studied by deuterium labelling: turnover of 4-hydroxy-3-methoxyphenylglycol.
    Mårdh G; Sjöquist B; Anggård E
    J Neurochem; 1983 Jul; 41(1):246-50. PubMed ID: 6864223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific and sensitive radioimmunoassay for 3-methoxy-4-hydroxyphenylethyleneglycol (MOPEG).
    Keeton TK; Krutzsch H; Lovenberg W
    Science; 1981 Feb; 211(4482):586-8. PubMed ID: 7455697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral clonidine on plasma 3-methoxy-4-hydroxyphenethyleneglycol (MHPG) in man: preliminary report.
    Leckman JF; Maas JW; Redmond DE; Heninger GR
    Life Sci; 1980 Jun; 26(25):2179-85. PubMed ID: 7401917
    [No Abstract]   [Full Text] [Related]  

  • 18. 3-Methoxy-4-hydroxyphenethyleneglycol increase in plasma after stimulation of the nucleus locus coeruleus.
    Crawley JN; Hattox SE; Maas JW; Roth RH
    Brain Res; 1978 Feb; 141(2):380-4. PubMed ID: 626910
    [No Abstract]   [Full Text] [Related]  

  • 19. Increase in plasma 3-methoxy-4-hydroxyphenethyleneglycol following stimulation of the nucleus locus coeruleus [proceedings].
    Crawley JN; Maas JW; Roth RH
    Psychopharmacol Bull; 1979 Apr; 15(2):27-9. PubMed ID: 107543
    [No Abstract]   [Full Text] [Related]  

  • 20. Disposition and metabolism of MHPG in humans: application to studies in depression.
    Kopin IJ; Jimerson DC; Markey SP; Ebert MH; Polinsky RJ
    Pharmacopsychiatry; 1984 Jan; 17(1):3-8. PubMed ID: 6369349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.